(844614, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844615, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844616, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844617, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844618, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844619, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844620, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844621, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844622, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844623, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844624, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844625, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844626, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844627, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844628, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844629, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844630, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844631, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844632, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844633, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844634, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844635, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844636, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844637, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844638, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844639, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844640, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844641, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844642, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844643, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844644, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844645, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844646, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844647, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844648, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844649, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844650, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844651, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844652, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844653, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844654, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844655, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844656, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844657, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844658, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844659, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844660, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844661, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844662, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844663, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844664, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844665, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844666, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844667, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844668, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844669, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844670, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844671, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844672, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844673, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844674, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844675, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844676, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844677, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844678, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844679, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844680, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844681, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844682, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844683, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844684, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844685, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844686, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844687, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844688, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844689, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844690, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844691, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844692, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844693, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844694, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844695, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844696, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844697, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844698, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844699, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844700, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844701, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844702, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844703, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844704, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844705, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844706, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844707, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844708, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844709, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844710, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844711, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844712, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844713, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844714, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844715, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844716, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844717, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844718, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844719, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844720, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844721, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844722, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844723, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844724, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844725, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844726, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844727, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844728, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844729, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844730, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844731, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844732, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844733, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844734, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844735, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844736, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844737, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844738, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844739, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844740, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844741, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844742, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844743, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844744, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844745, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844746, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844747, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844748, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844749, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844750, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844751, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844752, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844753, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844754, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844755, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844756, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844757, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844758, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844759, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844760, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844761, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844762, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844763, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844764, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844765, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844766, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844767, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844768, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844769, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844770, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844771, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844772, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844773, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844774, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844775, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844776, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844777, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844778, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844779, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844780, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844781, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844782, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844783, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844784, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844785, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844786, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844787, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844788, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844789, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844790, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844791, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844792, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844793, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844794, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844795, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844796, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844797, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844798, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844799, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844800, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844801, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844802, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844803, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844804, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844805, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844806, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844807, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844808, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844809, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844810, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844811, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844812, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844813, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844814, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844815, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844816, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844817, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844818, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844819, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844820, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844821, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844822, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844823, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844824, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844825, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844826, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844827, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844828, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844829, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844830, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844831, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844832, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844833, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844834, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844835, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844836, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844837, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844838, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844839, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844840, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844841, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844842, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844843, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844844, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844845, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844846, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844847, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844848, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844849, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844850, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844851, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844852, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844853, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844854, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844855, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844856, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844857, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844858, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844859, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844860, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844861, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844862, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844863, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844864, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844865, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844866, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844867, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844868, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844869, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844870, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844871, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844872, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844873, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844874, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844875, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844876, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844877, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844878, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844879, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844880, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844881, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844882, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844883, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844884, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844885, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844886, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844887, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844888, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844889, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844890, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844891, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844892, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844893, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844894, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844895, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844896, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844897, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844898, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844899, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844900, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844901, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844902, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844903, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844904, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844905, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844906, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844907, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844908, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844909, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844910, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844911, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844912, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844913, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844914, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844915, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844916, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844917, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844918, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844919, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844920, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844921, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844922, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844923, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844924, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844925, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844926, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844927, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844928, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844929, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844930, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844931, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844932, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844933, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844934, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844935, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844936, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844937, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844938, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844939, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844940, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844941, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844942, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844943, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844944, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844945, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844946, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844947, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844948, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844949, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844950, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844951, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844952, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844953, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844954, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844955, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844956, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844957, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844958, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844959, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844960, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844961, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844962, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844963, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844964, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844965, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844966, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844967, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844968, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844969, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844970, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844971, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844972, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844973, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844974, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844975, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844976, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844977, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844978, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844979, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844980, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844981, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844982, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844983, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844984, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844985, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844986, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844987, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844988, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844989, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844990, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844991, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844992, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844993, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844994, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844995, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844996, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(844997, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844998, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(844999, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845000, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845001, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845002, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845003, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845004, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845005, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845006, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845007, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845008, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845009, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845010, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845011, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845012, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845013, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845014, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845015, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845016, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845017, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845018, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845019, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845020, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845021, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845022, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845023, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845024, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845025, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845026, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845027, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845028, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845029, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845030, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845031, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845032, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845033, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845034, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845035, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845036, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845037, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845038, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845039, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845040, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845041, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845042, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845043, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845044, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845045, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845046, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845047, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845048, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845049, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845050, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845051, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845052, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845053, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845054, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845055, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845056, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845057, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845058, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845059, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845060, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845061, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845062, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845063, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845064, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845065, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845066, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845067, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845068, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845069, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845070, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845071, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845072, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845073, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845074, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845075, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845076, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845077, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845078, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845079, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845080, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845081, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845082, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845083, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845084, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845085, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845086, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845087, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845088, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845089, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845090, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845091, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845092, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845093, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845094, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845095, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845096, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845097, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845098, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845099, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845100, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845101, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845102, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845103, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845104, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845105, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845106, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845107, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845108, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845109, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845110, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845111, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845112, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845113, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845114, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845115, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845116, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845117, 'HP:0034117', 'Anti-angiotensin-converting enzyme 2 antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845118, 'HP:0500251', 'Abnormal urine sebacic acid concentration', 'MP:0011740', 'abnormal urine nitrite level', 0.44680851063829785, 9.150450616995217, 2.0220037615813, 'UPHENO:0081544', 'abnormal role urine level'),
(845119, 'HP:0500251', 'Abnormal urine sebacic acid concentration', 'MP:0030631', 'abnormal urine creatine level', 0.4107142857142857, 9.150450616995217, 1.9386131097057595, 'UPHENO:0081544', 'abnormal role urine level'),
(845120, 'HP:0500251', 'Abnormal urine sebacic acid concentration', 'MP:0009809', 'abnormal urine uric acid level', 0.44680851063829785, 9.150450616995217, 2.0220037615813, 'UPHENO:0081544', 'abnormal role urine level'),
(845121, 'HP:0500251', 'Abnormal urine sebacic acid concentration', 'MP:0011734', 'abnormal urine ammonia level', 0.4375, 9.150450616995217, 2.0008303638578178, 'UPHENO:0081544', 'abnormal role urine level'),
(845122, 'HP:0500251', 'Abnormal urine sebacic acid concentration', 'MP:0011458', 'abnormal urine chloride ion level', 0.42, 9.150450616995217, 1.9604053813275435, 'UPHENO:0081544', 'abnormal role urine level'),
(845123, 'HP:0500251', 'Abnormal urine sebacic acid concentration', 'MP:0001758', 'abnormal urine glucose level', 0.4375, 9.150450616995217, 2.0008303638578178, 'UPHENO:0081544', 'abnormal role urine level'),
(845124, 'HP:0500251', 'Abnormal urine sebacic acid concentration', 'MP:0009471', 'abnormal urine sulfate level', 0.4117647058823529, 9.150450616995217, 1.9410905715597173, 'UPHENO:0081544', 'abnormal role urine level'),
(845125, 'HP:0500251', 'Abnormal urine sebacic acid concentration', 'MP:0030782', 'abnormal urine glycerol level', 0.43137254901960786, 9.150450616995217, 1.9867695405686263, 'UPHENO:0081544', 'abnormal role urine level'),
(845126, 'HP:0500251', 'Abnormal urine sebacic acid concentration', 'MP:0006274', 'abnormal urine sodium level', 0.42, 9.150450616995217, 1.9604053813275435, 'UPHENO:0081544', 'abnormal role urine level'),
(845127, 'HP:0500251', 'Abnormal urine sebacic acid concentration', 'MP:0011469', 'abnormal urine creatinine level', 0.4423076923076923, 9.150450616995217, 2.011793899975505, 'UPHENO:0081544', 'abnormal role urine level'),
(845128, 'HP:0500251', 'Abnormal urine sebacic acid concentration', 'MP:0030777', 'abnormal urine citrate level', 0.42, 9.150450616995217, 1.9604053813275435, 'UPHENO:0081544', 'abnormal role urine level'),
(845129, 'HP:0500251', 'Abnormal urine sebacic acid concentration', 'MP:0011468', 'abnormal urine amino acid level', 0.4489795918367347, 9.150450616995217, 2.026910353997115, 'UPHENO:0081544', 'abnormal role urine level'),
(845130, 'HP:0500251', 'Abnormal urine sebacic acid concentration', 'MP:0004820', 'abnormal urine potassium level', 0.42, 9.150450616995217, 1.9604053813275435, 'UPHENO:0081544', 'abnormal role urine level'),
(845131, 'HP:0500251', 'Abnormal urine sebacic acid concentration', 'MP:0011478', 'abnormal urine catecholamine level', 0.40816326530612246, 9.150450616995217, 1.9325831942907894, 'UPHENO:0081544', 'abnormal role urine level'),
(845132, 'HP:0500251', 'Abnormal urine sebacic acid concentration', 'MP:0011552', 'abnormal urine deoxycorticosterone level', 0.45098039215686275, 9.150450616995217, 2.031421622328686, 'UPHENO:0081544', 'abnormal role urine level'),
(845133, 'HP:0003789', 'Minicore myopathy', 'MP:0002109', 'abnormal limb morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845134, 'HP:0003789', 'Minicore myopathy', 'MP:0020973', 'abnormal gland development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845135, 'HP:0003789', 'Minicore myopathy', 'MP:0002163', 'abnormal gland morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845136, 'HP:0003789', 'Minicore myopathy', 'MP:0012413', 'decreased muscle tumor incidence', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(845137, 'HP:0003789', 'Minicore myopathy', 'MP:0000428', 'abnormal craniofacial morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845138, 'HP:0003789', 'Minicore myopathy', 'MP:0003358', 'abnormal hypaxial muscle morphology', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(845139, 'HP:0003789', 'Minicore myopathy', 'MP:0002111', 'abnormal tail morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845140, 'HP:0003789', 'Minicore myopathy', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845141, 'HP:0003789', 'Minicore myopathy', 'MP:0013332', 'peliosis', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845142, 'HP:0003789', 'Minicore myopathy', 'MP:0002160', 'abnormal reproductive system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845143, 'HP:0003789', 'Minicore myopathy', 'MP:0000767', 'abnormal smooth muscle morphology', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(845144, 'HP:0003789', 'Minicore myopathy', 'MP:0005499', 'abnormal olfactory system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845145, 'HP:0003789', 'Minicore myopathy', 'MP:0014134', 'abnormal embryo morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845146, 'HP:0003789', 'Minicore myopathy', 'MP:0004134', 'abnormal chest morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845147, 'HP:0003789', 'Minicore myopathy', 'MP:0004233', 'abnormal muscle weight', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(845148, 'HP:0003789', 'Minicore myopathy', 'MP:0031310', 'abnormal cyst', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845149, 'HP:0003789', 'Minicore myopathy', 'MP:0003384', 'abnormal ventral body wall morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845150, 'HP:0003789', 'Minicore myopathy', 'MP:0013113', 'greasy tail', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845151, 'HP:0003789', 'Minicore myopathy', 'MP:0000759', 'abnormal skeletal muscle morphology', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(845152, 'HP:0003789', 'Minicore myopathy', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845153, 'HP:0003789', 'Minicore myopathy', 'MP:0005508', 'abnormal skeleton morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845154, 'HP:0003789', 'Minicore myopathy', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845155, 'HP:0003789', 'Minicore myopathy', 'MP:0005503', 'abnormal tendon morphology', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(845156, 'HP:0003789', 'Minicore myopathy', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845157, 'HP:0003789', 'Minicore myopathy', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845158, 'HP:0003789', 'Minicore myopathy', 'MP:0021138', 'abnormal multifidus muscle morphology', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(845159, 'HP:0003789', 'Minicore myopathy', 'MP:0004818', 'increased skeletal muscle mass', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(845160, 'HP:0003789', 'Minicore myopathy', 'MP:0003385', 'abnormal body wall morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845161, 'HP:0003789', 'Minicore myopathy', 'MP:0003397', 'increased muscle weight', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(845162, 'HP:0003789', 'Minicore myopathy', 'MP:0000749', 'muscle degeneration', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(845163, 'HP:0003789', 'Minicore myopathy', 'MP:0004817', 'abnormal skeletal muscle mass', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(845164, 'HP:0003789', 'Minicore myopathy', 'MP:0003939', 'abnormal myotome morphology', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(845165, 'HP:0003789', 'Minicore myopathy', 'MP:0010290', 'increased muscle tumor incidence', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(845166, 'HP:0003789', 'Minicore myopathy', 'MP:0000685', 'abnormal immune system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845167, 'HP:0003789', 'Minicore myopathy', 'MP:0003279', 'aneurysm', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845168, 'HP:0003789', 'Minicore myopathy', 'MP:0005500', 'abnormal gustatory system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845169, 'HP:0003789', 'Minicore myopathy', 'MP:0010233', 'hairless tail', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845170, 'HP:0003789', 'Minicore myopathy', 'MP:0010630', 'abnormal cardiac muscle tissue morphology', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(845171, 'HP:0003789', 'Minicore myopathy', 'MP:0000736', 'delayed muscle development', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(845172, 'HP:0003789', 'Minicore myopathy', 'MP:0013857', 'abnormal abdominal muscle morphology', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(845173, 'HP:0003789', 'Minicore myopathy', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845174, 'HP:0003789', 'Minicore myopathy', 'MP:0002132', 'abnormal respiratory system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845175, 'HP:0003789', 'Minicore myopathy', 'MP:0009408', 'decreased skeletal muscle fiber density', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(845176, 'HP:0003789', 'Minicore myopathy', 'MP:0000733', 'abnormal muscle development', 0.5217391304347826, 7.206267831629091, 1.9390182856678553, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(845177, 'HP:0003789', 'Minicore myopathy', 'MP:0000752', 'dystrophic muscle', 0.5217391304347826, 7.206267831629091, 1.9390182856678553, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(845178, 'HP:0003789', 'Minicore myopathy', 'MP:0002925', 'abnormal cardiovascular development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845179, 'HP:0003789', 'Minicore myopathy', 'MP:0000003', 'abnormal adipose tissue morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845180, 'HP:0003789', 'Minicore myopathy', 'MP:0003199', 'calcified muscle', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(845181, 'HP:0003789', 'Minicore myopathy', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845182, 'HP:0003789', 'Minicore myopathy', 'MP:0010678', 'abnormal skin adnexa morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845183, 'HP:0003789', 'Minicore myopathy', 'MP:0006281', 'abnormal tail development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845184, 'HP:0003789', 'Minicore myopathy', 'MP:0008923', 'thoracoschisis', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845185, 'HP:0003789', 'Minicore myopathy', 'MP:0013118', 'swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845186, 'HP:0003789', 'Minicore myopathy', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845187, 'HP:0003789', 'Minicore myopathy', 'MP:0020982', 'abnormal skin adnexa development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845188, 'HP:0003789', 'Minicore myopathy', 'MP:0000462', 'abnormal digestive system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845189, 'HP:0003789', 'Minicore myopathy', 'MP:0004248', 'abnormal epaxial muscle morphology', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(845190, 'HP:0003789', 'Minicore myopathy', 'MP:0009407', 'increased skeletal muscle fiber density', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(845191, 'HP:0003789', 'Minicore myopathy', 'MP:0002108', 'abnormal muscle morphology', 0.5454545454545454, 7.206267831629091, 1.9825971715214765, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(845192, 'HP:0003789', 'Minicore myopathy', 'MP:0004819', 'decreased skeletal muscle mass', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(845193, 'HP:0003789', 'Minicore myopathy', 'MP:0000731', 'increased collagen deposition in the muscles', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(845194, 'HP:0003789', 'Minicore myopathy', 'MP:0003632', 'abnormal nervous system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(845195, 'HP:0003789', 'Minicore myopathy', 'MP:0031112', 'rhabdomyolysis', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(845196, 'HP:0040114', 'Absence of the reflex of the tensor tympani muscle', 'MP:0001963', 'abnormal hearing physiology', 0.40540540540540543, 7.171824267787784, 1.7051382128082262, 'UPHENO:0002903', 'abnormal ear'),
(845197, 'HP:0040114', 'Absence of the reflex of the tensor tympani muscle', 'MP:0002102', 'abnormal ear morphology', 0.41025641025641024, 7.8051695233081215, 1.7894470738401644, 'UPHENO:0076730', 'abnormal ear morphology'),
(845198, 'HP:0040114', 'Absence of the reflex of the tensor tympani muscle', 'MP:0000049', 'abnormal middle ear morphology', 0.4146341463414634, 9.948935785159481, 2.0310510816534473, 'UPHENO:0003017', 'abnormal middle ear'),
(845199, 'HP:0040114', 'Absence of the reflex of the tensor tympani muscle', 'MP:0030227', 'abnormal tubotympanic recess morphology', 0.40476190476190477, 9.948935785159481, 2.006726239115597, 'UPHENO:0003017', 'abnormal middle ear'),
(845200, 'HP:0040114', 'Absence of the reflex of the tensor tympani muscle', 'MP:0030226', 'middle ear polyps', 0.40476190476190477, 9.948935785159481, 2.006726239115597, 'UPHENO:0003017', 'abnormal middle ear'),
(845201, 'HP:0040114', 'Absence of the reflex of the tensor tympani muscle', 'MP:0003878', 'abnormal ear physiology', 0.4166666666666667, 7.171824267787784, 1.7286584716415916, 'UPHENO:0002903', 'abnormal ear'),
(845202, 'HP:0002404', 'Thickened superior cerebellar peduncle', 'MP:0012447', 'thick cerebellar granule layer', 0.40298507462686567, 9.732678149995134, 1.9804353134084067, 'UPHENO:0076720', 'abnormal cerebellum morphology'),
(845203, 'HP:0002404', 'Thickened superior cerebellar peduncle', 'MP:0020567', 'increased pontocerebellar fibers size', 0.40540540540540543, 12.799792345853673, 2.2779607119254304, 'UPHENO:0081586', 'abnormal cerebellar peduncle morphology'),
(845204, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845205, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003633', 'abnormal nervous system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845206, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0011994', 'increased nerve conduction velocity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845207, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845208, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845209, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845210, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003482', 'increased nerve fiber response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845211, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003468', 'increased single cell response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845212, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845213, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0000920', 'abnormal myelination', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845214, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0000948', 'nonconvulsive seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845215, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0002578', 'impaired ability to fire action potentials', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845216, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003465', 'increased single cell response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845217, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845218, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845219, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845220, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003996', 'clonic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845221, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0008814', 'decreased nerve conduction velocity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845222, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845223, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0001752', 'abnormal hypothalamus secretion', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845224, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003480', 'increased nerve fiber response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845225, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0002635', 'reduced sensorimotor gating', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845226, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0021009', 'abnormal synaptic physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845227, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003216', 'absence seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845228, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0005402', 'abnormal action potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845229, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845230, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0009358', 'environmentally induced seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845231, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003466', 'decreased single cell response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845232, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003467', 'abnormal single cell response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845233, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0011397', 'endoneurial edema', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845234, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0000951', 'sporadic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845235, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0004994', 'abnormal brain wave pattern', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845236, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845237, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003469', 'decreased single cell response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845238, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0006080', 'brain ischemia', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845239, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.46875, 7.291997705654976, 1.8488168985937385, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845240, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003483', 'decreased nerve fiber response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845241, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845242, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0014120', 'focal seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845243, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0001912', 'increased cerebrospinal fluid production', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845244, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003476', 'decreased summary potential intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845245, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0002064', 'seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845246, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845247, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003635', 'abnormal synaptic transmission', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845248, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0021015', 'increased tau protein phosphorylation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845249, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003880', 'abnormal central pattern generator function', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845250, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0004859', 'abnormal synaptic plasticity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845251, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003889', 'enhanced sensorimotor gating', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845252, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845253, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003472', 'increased summary potential threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845254, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.4411764705882353, 7.291997705654976, 1.793615848312668, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845255, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845256, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845257, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003471', 'abnormal summary potential threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845258, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845259, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003470', 'abnormal summary potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845260, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0000947', 'convulsive seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845261, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003477', 'abnormal nerve fiber response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845262, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.46875, 7.291997705654976, 1.8488168985937385, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845263, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845264, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0004513', 'avnosmia', 0.45454545454545453, 7.291997705654976, 1.8205890287655127, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845265, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845266, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845267, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003474', 'abnormal summary potential intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845268, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845269, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845270, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845271, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0021010', 'impaired synaptic physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845272, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845273, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0012006', 'abnormal hippocampus physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845274, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845275, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845276, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845277, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003473', 'decreased summary potential threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845278, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003464', 'abnormal single cell response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845279, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845280, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0012011', 'febrile seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845281, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0002826', 'tonic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845282, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003997', 'tonic-clonic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845283, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0013806', 'encephalopathy', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845284, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845285, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.4411764705882353, 7.291997705654976, 1.793615848312668, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845286, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003463', 'abnormal single cell response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845287, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0005403', 'abnormal nerve conduction', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845288, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845289, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003481', 'decreased nerve fiber response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845290, 'HP:0040129', 'Abnormal nerve conduction velocity', 'MP:0003475', 'increased summary potential intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845291, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845292, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845293, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845294, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845295, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0031088', 'coughing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845296, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845297, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845298, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845299, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845300, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845301, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845302, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845303, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845304, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0031089', 'sneezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845305, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845306, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845307, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845308, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845309, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845310, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845311, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845312, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845313, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845314, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0003298', 'choking', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845315, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845316, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845317, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845318, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845319, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845320, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0013942', 'enthesitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845321, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845322, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845323, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845324, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0031092', 'dysgeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845325, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845326, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845327, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845328, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845329, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845330, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845331, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845332, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845333, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845334, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845335, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845336, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845337, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001756', 'abnormal urination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845338, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845339, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845340, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845341, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845342, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845343, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845344, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845345, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845346, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845347, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845348, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845349, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845350, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845351, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845352, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845353, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845354, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845355, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845356, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845357, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845358, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0031095', 'pharyngitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845359, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845360, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845361, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845362, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845363, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845364, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845365, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845366, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845367, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0031090', 'ageusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845368, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845369, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0000751', 'myopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845370, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845371, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845372, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0003746', 'stomatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845373, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845374, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0006080', 'brain ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845375, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845376, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845377, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845378, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845379, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0010822', 'pneumothorax', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845380, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845381, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845382, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845383, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845384, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845385, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004947', 'skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845386, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845387, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845388, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845389, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845390, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845391, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845392, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845393, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845394, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845395, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845396, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845397, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845398, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845399, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001943', 'abnormal respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845400, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845401, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845402, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845403, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845404, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845405, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0010994', 'aerophagia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845406, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845407, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845408, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845409, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0012565', 'perivasculitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845410, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845411, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0013806', 'encephalopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845412, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845413, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845414, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845415, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845416, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0000313', 'abnormal cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845417, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845418, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845419, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845420, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845421, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845422, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845423, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845424, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001847', 'brain inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845425, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845426, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845427, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845428, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845429, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845430, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845431, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845432, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845433, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845434, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845435, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845436, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845437, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845438, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845439, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845440, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845441, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845442, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845443, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845444, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845445, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845446, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845447, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845448, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845449, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845450, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845451, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845452, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845453, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845454, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845455, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845456, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845457, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845458, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0003777', 'lip inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845459, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845460, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845461, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845462, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008544', 'impaired olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845463, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845464, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004558', 'delayed allantois development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845465, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0030988', 'dysosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845466, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845467, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845468, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845469, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845470, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845471, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845472, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845473, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845474, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0031302', 'syncope', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845475, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845476, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845477, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845478, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845479, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845480, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845481, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845482, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845483, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845484, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845485, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845486, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845487, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845488, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845489, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845490, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845491, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845492, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845493, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845494, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845495, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845496, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845497, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845498, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845499, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845500, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845501, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845502, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845503, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845504, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845505, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845506, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845507, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845508, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845509, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0006082', 'CNS inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845510, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845511, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845512, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845513, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845514, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845515, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0031110', 'meningitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845516, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845517, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845518, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845519, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845520, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845521, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845522, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845523, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005044', 'sepsis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845524, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845525, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845526, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845527, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845528, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845529, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845530, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845531, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845532, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845533, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845534, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845535, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845536, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845537, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845538, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845539, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845540, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845541, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845542, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0030129', 'tongue inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845543, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845544, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845545, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845546, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845547, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845548, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845549, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845550, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845551, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845552, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845553, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845554, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0009046', 'muscle twitch', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845555, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845556, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001844', 'autoimmune response', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845557, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845558, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845559, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0009697', 'abnormal copulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845560, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0013136', 'genital discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845561, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845562, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845563, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845564, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845565, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845566, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845567, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845568, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845569, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845570, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845571, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845572, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845573, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845574, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0003767', 'palate inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845575, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845576, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845577, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845578, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845579, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845580, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845581, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001873', 'stomach inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845582, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845583, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845584, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845585, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845586, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0031066', 'cytokine storm', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845587, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845588, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001861', 'lung inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845589, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845590, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845591, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845592, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845593, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845594, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845595, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0030990', 'nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845596, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845597, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845598, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845599, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845600, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845601, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845602, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845603, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845604, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845605, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845606, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845607, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845608, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0031102', 'rhinorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845609, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845610, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845611, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845612, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845613, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005190', 'osteomyelitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845614, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845615, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845616, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845617, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0011763', 'urethritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845618, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845619, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845620, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845621, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845622, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845623, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845624, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845625, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845626, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845627, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845628, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845629, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845630, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845631, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845632, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004510', 'myositis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845633, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845634, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845635, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845636, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845637, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845638, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845639, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845640, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845641, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845642, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0031053', 'pleuritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845643, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845644, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845645, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845646, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845647, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845648, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845649, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845650, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845651, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845652, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0031091', 'hypogeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845653, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845654, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845655, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845656, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845657, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0011764', 'ureteritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845658, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845659, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845660, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845661, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001664', 'abnormal digestion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845662, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845663, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004512', 'anosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845664, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845665, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845666, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845667, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845668, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845669, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845670, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845671, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845672, 'HP:0034085', 'Anti-PM-Scl100 antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(845673, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0004994', 'abnormal brain wave pattern', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845674, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003464', 'abnormal single cell response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845675, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0002635', 'reduced sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845676, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0002826', 'tonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845677, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0000920', 'abnormal myelination', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845678, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0004513', 'avnosmia', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845679, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845680, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845681, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0004811', 'abnormal neuron physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845682, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0031092', 'dysgeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845683, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003217', 'increased spike-wave discharge type I', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845684, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0011994', 'increased nerve conduction velocity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845685, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0002914', 'abnormal endplate potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845686, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0001984', 'abnormal olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845687, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0004494', 'abnormal synaptic glutamate release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845688, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845689, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003482', 'increased nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845690, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845691, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845692, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845693, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003997', 'tonic-clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845694, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0020424', 'increased kindling response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845695, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0004835', 'abnormal miniature endplate potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845696, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0008840', 'abnormal spike wave discharge', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845697, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0009358', 'environmentally induced seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845698, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0012685', 'abnormal primitive streak elongation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845699, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0005403', 'abnormal nerve conduction', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845700, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003088', 'abnormal prepulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845701, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003216', 'absence seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845702, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845703, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0000948', 'nonconvulsive seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845704, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0001986', 'abnormal taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845705, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003990', 'decreased neurotransmitter release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845706, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003486', 'abnormal channel response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845707, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0001919', 'abnormal reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845708, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845709, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003635', 'abnormal synaptic transmission', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845710, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0004558', 'delayed allantois development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845711, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0001983', 'abnormal olfactory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845712, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0013806', 'encephalopathy', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845713, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0006082', 'CNS inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845714, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845715, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845716, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0001499', 'abnormal kindling response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845717, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845718, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0014252', 'abnormal paired-pulse ratio', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845719, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0001500', 'decreased kindling response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845720, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0006080', 'brain ischemia', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845721, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0014253', 'decreased paired-pulse ratio', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845722, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003477', 'abnormal nerve fiber response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845723, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845724, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003475', 'increased summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845725, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0011397', 'endoneurial edema', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845726, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845727, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845728, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845729, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0001533', 'abnormal skeleton physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845730, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003220', 'decreased spike-wave discharge type II', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845731, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845732, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845733, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845734, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845735, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845736, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0002106', 'abnormal muscle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845737, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845738, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845739, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845740, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845741, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0000947', 'convulsive seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845742, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845743, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845744, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845745, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0005666', 'abnormal adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845746, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0012011', 'febrile seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845747, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003485', 'abnormal channel response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845748, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0010149', 'abnormal synaptic dopamine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845749, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845750, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003469', 'decreased single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845751, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0002195', 'psychomotor seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845752, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845753, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0000951', 'sporadic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845754, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0002578', 'impaired ability to fire action potentials', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845755, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003470', 'abnormal summary potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845756, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845757, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845758, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845759, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0006060', 'increased cerebral infarct size', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845760, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845761, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845762, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845763, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0013438', 'dysmyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845764, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0012006', 'abnormal hippocampus physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845765, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0002634', 'abnormal sensorimotor gating', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845766, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845767, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0005402', 'abnormal action potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845768, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003218', 'decreased spike-wave discharge type I', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845769, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845770, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845771, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0001496', 'audiogenic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845772, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0004859', 'abnormal synaptic plasticity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845773, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845774, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845775, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003476', 'decreased summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845776, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003466', 'decreased single cell response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845777, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845778, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003480', 'increased nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845779, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003468', 'increased single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845780, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845781, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845782, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0004768', 'abnormal axonal transport', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845783, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845784, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845785, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845786, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0021009', 'abnormal synaptic physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845787, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0014120', 'focal seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845788, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0006058', 'decreased cerebral infarct size', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845789, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0014255', 'increased paired-pulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845790, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0014256', 'decreased paired-pulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845791, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845792, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003880', 'abnormal central pattern generator function', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845793, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845794, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003996', 'clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845795, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0001985', 'abnormal gustatory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845796, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0001900', 'impaired synaptic plasticity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845797, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0010050', 'hypermyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845798, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003467', 'abnormal single cell response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845799, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003474', 'abnormal summary potential intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845800, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0001912', 'increased cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845801, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0001663', 'abnormal digestive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845802, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845803, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845804, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0001790', 'abnormal immune system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845805, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0021010', 'impaired synaptic physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845806, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003483', 'decreased nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845807, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003633', 'abnormal nervous system physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845808, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845809, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845810, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845811, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845812, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003473', 'decreased summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845813, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845814, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0002164', 'abnormal gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845815, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0014254', 'increased paired-pulse ratio', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845816, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845817, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0010680', 'abnormal skin adnexa physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845818, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003472', 'increased summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845819, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0002193', 'minimal clonic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845820, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0005621', 'abnormal cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845821, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003481', 'decreased nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845822, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003463', 'abnormal single cell response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845823, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845824, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845825, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845826, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845827, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0002133', 'abnormal respiratory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845828, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0000921', 'demyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845829, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845830, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0001752', 'abnormal hypothalamus secretion', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845831, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0008921', 'increased neurotransmitter release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845832, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845833, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845834, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0008814', 'decreased nerve conduction velocity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845835, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003465', 'increased single cell response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845836, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845837, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003471', 'abnormal summary potential threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845838, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0002920', 'decreased paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845839, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845840, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845841, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0002207', 'abnormal long-term potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845842, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0021015', 'increased tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845843, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003889', 'enhanced sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845844, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003219', 'increased spike-wave discharge type II', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845845, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0030990', 'nerve inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845846, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0000427', 'abnormal hair cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845847, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0002064', 'seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845848, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0002915', 'abnormal synaptic depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845849, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0021001', 'impaired neuron physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845850, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845851, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0003484', 'abnormal channel response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845852, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845853, 'HP:0002123', 'Generalized myoclonic seizure', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(845854, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0008247', 'abnormal mononuclear cell morphology', 0.41509433962264153, 8.865680281510128, 1.9183570318788215, 'UPHENO:0085017', 'abnormal mononuclear cell morphology'),
(845855, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0010837', 'abnormal CD8-positive, alpha-beta memory T cell morphology', 0.40625, 10.92532322793753, 2.106754034373643, 'UPHENO:0084898', 'abnormal alpha-beta T cell morphology'),
(845856, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0013760', 'abnormal T-helper cell morphology', 0.423728813559322, 9.765845013930333, 2.034224648645503, 'UPHENO:0085072', 'abnormal T cell morphology'),
(845857, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0002436', 'abnormal CD8-positive, alpha-beta cytotoxic T cell morphology', 0.41935483870967744, 10.92532322793753, 2.140464239388931, 'UPHENO:0084898', 'abnormal alpha-beta T cell morphology'),
(845858, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0002439', 'abnormal plasma cell morphology', 0.41379310344827586, 9.03982492632585, 1.934067530075787, 'UPHENO:0084888', 'abnormal lymphocyte morphology'),
(845859, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0008036', 'abnormal NK T cell morphology', 0.43333333333333335, 10.92532322793753, 2.1758462105825087, 'UPHENO:0084898', 'abnormal alpha-beta T cell morphology'),
(845860, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0005068', 'abnormal NK cell morphology', 0.42857142857142855, 9.03982492632585, 1.9683014715005114, 'UPHENO:0084888', 'abnormal lymphocyte morphology'),
(845861, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0008344', 'abnormal mature gamma-delta T cell morphology', 0.423728813559322, 9.765845013930333, 2.034224648645503, 'UPHENO:0085072', 'abnormal T cell morphology'),
(845862, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0008397', 'abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology', 0.40625, 10.92532322793753, 2.106754034373643, 'UPHENO:0084898', 'abnormal alpha-beta T cell morphology'),
(845863, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0010834', 'abnormal CD4-positive, alpha-beta memory T cell morphology', 0.40625, 10.92532322793753, 2.106754034373643, 'UPHENO:0084898', 'abnormal alpha-beta T cell morphology'),
(845864, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0010671', 'abnormal Tc17 cell morphology', 0.41935483870967744, 10.92532322793753, 2.140464239388931, 'UPHENO:0084898', 'abnormal alpha-beta T cell morphology'),
(845865, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0002432', 'abnormal CD4-positive, alpha beta T cell morphology', 0.43333333333333335, 10.92532322793753, 2.1758462105825087, 'UPHENO:0084898', 'abnormal alpha-beta T cell morphology'),
(845866, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0008081', 'abnormal single-positive T cell number', 0.43103448275862066, 9.765845013930333, 2.051686124698492, 'UPHENO:0085072', 'abnormal T cell morphology'),
(845867, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0004941', 'abnormal regulatory T cell morphology', 0.43859649122807015, 9.765845013930333, 2.069605121028402, 'UPHENO:0085072', 'abnormal T cell morphology'),
(845868, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0010183', 'abnormal CD4-positive helper T cell morphology', 0.40625, 10.92532322793753, 2.106754034373643, 'UPHENO:0084898', 'abnormal alpha-beta T cell morphology'),
(845869, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0005010', 'abnormal CD8-positive, alpha beta T cell morphology', 0.43333333333333335, 10.92532322793753, 2.1758462105825087, 'UPHENO:0084898', 'abnormal alpha-beta T cell morphology'),
(845870, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0010833', 'abnormal memory T cell morphology', 0.43859649122807015, 9.765845013930333, 2.069605121028402, 'UPHENO:0085072', 'abnormal T cell morphology'),
(845871, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0002403', 'abnormal pre-B cell morphology', 0.42105263157894735, 9.03982492632585, 1.95095927026744, 'UPHENO:0084888', 'abnormal lymphocyte morphology'),
(845872, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0013700', 'abnormal mature NK cell morphology', 0.41379310344827586, 9.03982492632585, 1.934067530075787, 'UPHENO:0084888', 'abnormal lymphocyte morphology'),
(845873, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0002619', 'abnormal lymphocyte morphology', 0.4444444444444444, 9.03982492632585, 2.004420107476457, 'UPHENO:0084888', 'abnormal lymphocyte morphology'),
(845874, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0012762', 'abnormal alpha-beta T cell morphology', 0.4642857142857143, 10.92532322793753, 2.252214798522841, 'UPHENO:0084898', 'abnormal alpha-beta T cell morphology'),
(845875, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0008398', 'abnormal CD8-positive, alpha-beta regulatory T cell morphology', 0.40625, 10.92532322793753, 2.106754034373643, 'UPHENO:0084898', 'abnormal alpha-beta T cell morphology'),
(845876, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0002435', 'abnormal effector T cell morphology', 0.43859649122807015, 9.765845013930333, 2.069605121028402, 'UPHENO:0085072', 'abnormal T cell morphology'),
(845877, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0008037', 'abnormal T cell morphology', 0.45454545454545453, 9.765845013930333, 2.1068983034018096, 'UPHENO:0085072', 'abnormal T cell morphology'),
(845878, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0008894', 'abnormal intraepithelial T cell morphology', 0.43859649122807015, 9.765845013930333, 2.069605121028402, 'UPHENO:0085072', 'abnormal T cell morphology'),
(845879, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0004939', 'abnormal B cell morphology', 0.42857142857142855, 9.03982492632585, 1.9683014715005114, 'UPHENO:0084888', 'abnormal lymphocyte morphology'),
(845880, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0008343', 'abnormal gamma-delta T cell morphology', 0.43859649122807015, 9.765845013930333, 2.069605121028402, 'UPHENO:0085072', 'abnormal T cell morphology'),
(845881, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0008246', 'abnormal leukocyte morphology', 0.40384615384615385, 8.546451336223722, 1.8578082519913814, 'UPHENO:0085042', 'abnormal leukocyte morphology'),
(845882, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0013699', 'abnormal immature NK cell morphology', 0.41379310344827586, 9.03982492632585, 1.934067530075787, 'UPHENO:0084888', 'abnormal lymphocyte morphology'),
(845883, 'HP:0030336', 'Absence of CD4-positive, CD25-positive regulatory T cells', 'MP:0008399', 'abnormal alpha-beta intraepithelial T cell morphology', 0.41935483870967744, 10.92532322793753, 2.140464239388931, 'UPHENO:0084898', 'abnormal alpha-beta T cell morphology'),
(845884, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0002897', 'blotchy skin', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845885, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0001212', 'skin lesions', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845886, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0003196', 'calcified skin', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845887, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0011515', 'purpura', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845888, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0003853', 'dry skin', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845889, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0010016', 'variable depigmentation', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845890, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0009606', 'increased keratohyalin granule size', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845891, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0009605', 'decreased keratohyalin granule number', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845892, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0002095', 'abnormal skin pigmentation', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845893, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0012078', 'abnormal tail ring morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845894, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0005081', 'abnormal dermis reticular layer morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845895, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0003717', 'pallor', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845896, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0009932', 'skin fibrosis', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845897, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0009604', 'increased keratohyalin granule number', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845898, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0011239', 'abnormal skin coloration', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845899, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0009602', 'abnormal keratohyalin granule morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845900, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0001192', 'scaly skin', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845901, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0010232', 'delayed skin pigmentation appearance', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845902, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0009827', 'skin detachment', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845903, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0011160', 'dermal-epidermal separation', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845904, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0008854', 'bleb', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845905, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0001231', 'abnormal epidermis stratum basale morphology', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845906, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0001209', 'spontaneous skin ulceration', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845907, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0009387', 'abnormal epidermal pigmentation', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845908, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0001216', 'abnormal epidermal layer morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845909, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0001196', 'shiny skin', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845910, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0001210', 'skin ridges', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845911, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0031103', 'skin rash', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845912, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0009931', 'abnormal skin appearance', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845913, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0001246', 'mixed cellular infiltration to dermis', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845914, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0001193', 'psoriasis', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845915, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0001239', 'abnormal epidermis stratum granulosum morphology', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845916, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0009610', 'abnormal epidermis stratum lucidum morphology', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845917, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0001213', 'abnormal skin cell number', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845918, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0009385', 'abnormal dermal pigmentation', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845919, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0001201', 'translucent skin', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845920, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0002015', 'epithelioid cyst', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845921, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0003941', 'abnormal skin development', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845922, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0001195', 'flaky skin', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845923, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0009545', 'abnormal dermis papillary layer morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845924, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0001230', 'epidermal desquamation', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845925, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0008419', 'abnormal cutaneous microfibril morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845926, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0003940', 'abnormal dermatome morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845927, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0009563', 'dyskeratosis', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845928, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0008438', 'abnormal cutaneous collagen fibril morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845929, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0001243', 'abnormal dermal layer morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845930, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0003652', 'abnormal skin turgor', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845931, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0008816', 'petechiae', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845932, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0001191', 'abnormal skin condition', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845933, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0004241', 'acantholysis', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845934, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0011159', 'abnormal epidermal-dermal junction morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845935, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0009379', 'abnormal foot pigmentation', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845936, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0001233', 'abnormal epidermis suprabasal layer morphology', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845937, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0003653', 'decreased skin turgor', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845938, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0013406', 'abnormal epidermal immune compartment', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845939, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0008856', 'fetal bleb', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845940, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0009607', 'decreased keratohyalin granule size', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845941, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0001236', 'abnormal epidermis stratum spinosum morphology', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845942, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0005421', 'loose skin', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845943, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0002060', 'abnormal skin morphology', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845944, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0001208', 'blistering', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845945, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0001198', 'tight skin', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845946, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0009441', 'delayed skin barrier formation', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845947, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0010206', 'pigment incontinence', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845948, 'HP:0012540', 'Axillary epidermoid cyst', 'MP:0008418', 'abnormal cutaneous elastic fiber morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(845949, 'HP:0040052', 'Abnormality of lower eyelashes', 'MP:0013895', 'abnormal eyelid cilium morphology', 0.4090909090909091, 12.66854781257542, 2.2765297585377895, 'UPHENO:0076771', 'abnormal eyelash morphology'),
(845950, 'HP:0001339', 'Lissencephaly', 'MP:0020066', 'abnormal neocortex size', 0.4074074074074074, 9.50911518495075, 1.9682692814346299, 'UPHENO:0081603', 'abnormal cerebral cortex morphology'),
(845951, 'HP:0001339', 'Lissencephaly', 'MP:0000791', 'delaminated cerebral cortex', 0.4230769230769231, 9.50911518495075, 2.005763493942646, 'UPHENO:0081603', 'abnormal cerebral cortex morphology'),
(845952, 'HP:0001339', 'Lissencephaly', 'MP:0020569', 'abnormal premotor cortex size', 0.4074074074074074, 9.50911518495075, 1.9682692814346299, 'UPHENO:0081603', 'abnormal cerebral cortex morphology'),
(845953, 'HP:0012452', 'Restless legs', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845954, 'HP:0012452', 'Restless legs', 'MP:0003474', 'abnormal summary potential intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845955, 'HP:0012452', 'Restless legs', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845956, 'HP:0012452', 'Restless legs', 'MP:0003468', 'increased single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845957, 'HP:0012452', 'Restless legs', 'MP:0003880', 'abnormal central pattern generator function', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845958, 'HP:0012452', 'Restless legs', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845959, 'HP:0012452', 'Restless legs', 'MP:0004994', 'abnormal brain wave pattern', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845960, 'HP:0012452', 'Restless legs', 'MP:0011994', 'increased nerve conduction velocity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845961, 'HP:0012452', 'Restless legs', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845962, 'HP:0012452', 'Restless legs', 'MP:0000948', 'nonconvulsive seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845963, 'HP:0012452', 'Restless legs', 'MP:0005403', 'abnormal nerve conduction', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845964, 'HP:0012452', 'Restless legs', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845965, 'HP:0012452', 'Restless legs', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845966, 'HP:0012452', 'Restless legs', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845967, 'HP:0012452', 'Restless legs', 'MP:0002064', 'seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845968, 'HP:0012452', 'Restless legs', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845969, 'HP:0012452', 'Restless legs', 'MP:0003472', 'increased summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845970, 'HP:0012452', 'Restless legs', 'MP:0012011', 'febrile seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845971, 'HP:0012452', 'Restless legs', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845972, 'HP:0012452', 'Restless legs', 'MP:0021009', 'abnormal synaptic physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845973, 'HP:0012452', 'Restless legs', 'MP:0003633', 'abnormal nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845974, 'HP:0012452', 'Restless legs', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845975, 'HP:0012452', 'Restless legs', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845976, 'HP:0012452', 'Restless legs', 'MP:0003480', 'increased nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845977, 'HP:0012452', 'Restless legs', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845978, 'HP:0012452', 'Restless legs', 'MP:0002634', 'abnormal sensorimotor gating', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845979, 'HP:0012452', 'Restless legs', 'MP:0003482', 'increased nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845980, 'HP:0012452', 'Restless legs', 'MP:0005645', 'abnormal hypothalamus physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845981, 'HP:0012452', 'Restless legs', 'MP:0008814', 'decreased nerve conduction velocity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845982, 'HP:0012452', 'Restless legs', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845983, 'HP:0012452', 'Restless legs', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845984, 'HP:0012452', 'Restless legs', 'MP:0013806', 'encephalopathy', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845985, 'HP:0012452', 'Restless legs', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845986, 'HP:0012452', 'Restless legs', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845987, 'HP:0012452', 'Restless legs', 'MP:0001912', 'increased cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845988, 'HP:0012452', 'Restless legs', 'MP:0000947', 'convulsive seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845989, 'HP:0012452', 'Restless legs', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845990, 'HP:0012452', 'Restless legs', 'MP:0014120', 'focal seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845991, 'HP:0012452', 'Restless legs', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845992, 'HP:0012452', 'Restless legs', 'MP:0002635', 'reduced sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845993, 'HP:0012452', 'Restless legs', 'MP:0000951', 'sporadic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845994, 'HP:0012452', 'Restless legs', 'MP:0002578', 'impaired ability to fire action potentials', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845995, 'HP:0012452', 'Restless legs', 'MP:0003889', 'enhanced sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845996, 'HP:0012452', 'Restless legs', 'MP:0003471', 'abnormal summary potential threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845997, 'HP:0012452', 'Restless legs', 'MP:0003464', 'abnormal single cell response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845998, 'HP:0012452', 'Restless legs', 'MP:0003477', 'abnormal nerve fiber response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(845999, 'HP:0012452', 'Restless legs', 'MP:0012006', 'abnormal hippocampus physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846000, 'HP:0012452', 'Restless legs', 'MP:0021015', 'increased tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846001, 'HP:0012452', 'Restless legs', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846002, 'HP:0012452', 'Restless legs', 'MP:0003481', 'decreased nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846003, 'HP:0012452', 'Restless legs', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846004, 'HP:0012452', 'Restless legs', 'MP:0005402', 'abnormal action potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846005, 'HP:0012452', 'Restless legs', 'MP:0003470', 'abnormal summary potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846006, 'HP:0012452', 'Restless legs', 'MP:0003475', 'increased summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846007, 'HP:0012452', 'Restless legs', 'MP:0003467', 'abnormal single cell response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846008, 'HP:0012452', 'Restless legs', 'MP:0003476', 'decreased summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846009, 'HP:0012452', 'Restless legs', 'MP:0006080', 'brain ischemia', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846010, 'HP:0012452', 'Restless legs', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846011, 'HP:0012452', 'Restless legs', 'MP:0003473', 'decreased summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846012, 'HP:0012452', 'Restless legs', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846013, 'HP:0012452', 'Restless legs', 'MP:0003466', 'decreased single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846014, 'HP:0012452', 'Restless legs', 'MP:0003465', 'increased single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846015, 'HP:0012452', 'Restless legs', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846016, 'HP:0012452', 'Restless legs', 'MP:0003463', 'abnormal single cell response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846017, 'HP:0012452', 'Restless legs', 'MP:0003469', 'decreased single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846018, 'HP:0012452', 'Restless legs', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846019, 'HP:0012452', 'Restless legs', 'MP:0003483', 'decreased nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846020, 'HP:0012452', 'Restless legs', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846021, 'HP:0012452', 'Restless legs', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846022, 'HP:0007554', 'Confetti hypopigmentation pattern of lower leg skin', 'MP:0011279', 'decreased ear pigmentation', 0.4225352112676056, 12.607147267911277, 2.3080215844590164, 'UPHENO:0077885', 'decreased pigmentation in skin of body'),
(846023, 'HP:0007554', 'Confetti hypopigmentation pattern of lower leg skin', 'MP:0011568', 'decreased foot pigmentation', 0.5769230769230769, 12.607147267911277, 2.6969156814824107, 'UPHENO:0077885', 'decreased pigmentation in skin of body'),
(846024, 'HP:0007554', 'Confetti hypopigmentation pattern of lower leg skin', 'MP:0020221', 'reduced foot pad pigmentation', 0.4225352112676056, 12.607147267911277, 2.3080215844590164, 'UPHENO:0077885', 'decreased pigmentation in skin of body'),
(846025, 'HP:0007554', 'Confetti hypopigmentation pattern of lower leg skin', 'MP:0030930', 'decreased digit pigmentation', 0.5, 12.607147267911277, 2.5106918636016724, 'UPHENO:0077885', 'decreased pigmentation in skin of body'),
(846026, 'HP:0007554', 'Confetti hypopigmentation pattern of lower leg skin', 'MP:0011277', 'decreased tail pigmentation', 0.5555555555555556, 12.607147267911277, 2.646501597278028, 'UPHENO:0077885', 'decreased pigmentation in skin of body'),
(846027, 'HP:0007554', 'Confetti hypopigmentation pattern of lower leg skin', 'MP:0030054', 'decreased forehead pigmentation', 0.4166666666666667, 12.607147267911277, 2.2919376143988663, 'UPHENO:0077885', 'decreased pigmentation in skin of body'),
(846028, 'HP:0007554', 'Confetti hypopigmentation pattern of lower leg skin', 'MP:0005408', 'hypopigmentation', 0.5609756097560976, 12.285219173023913, 2.625206337904583, 'UPHENO:0077877', 'decreased pigmentation in multicellular organism'),
(846029, 'HP:0007554', 'Confetti hypopigmentation pattern of lower leg skin', 'MP:0005172', 'decreased eye pigmentation', 0.4032258064516129, 12.285219173023913, 2.2256948147662525, 'UPHENO:0077877', 'decreased pigmentation in multicellular organism'),
(846030, 'HP:0007554', 'Confetti hypopigmentation pattern of lower leg skin', 'MP:0011627', 'decreased skin pigmentation', 0.6382978723404256, 12.607147267911277, 2.836743780708821, 'UPHENO:0077885', 'decreased pigmentation in skin of body'),
(846031, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0013806', 'encephalopathy', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846032, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0003477', 'abnormal nerve fiber response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846033, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846034, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846035, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846036, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0004994', 'abnormal brain wave pattern', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846037, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846038, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0021015', 'increased tau protein phosphorylation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846039, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0003463', 'abnormal single cell response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846040, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846041, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0003633', 'abnormal nervous system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846042, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846043, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0006080', 'brain ischemia', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846044, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0002634', 'abnormal sensorimotor gating', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846045, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846046, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0005402', 'abnormal action potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846047, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846048, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846049, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0002635', 'reduced sensorimotor gating', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846050, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846051, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0003880', 'abnormal central pattern generator function', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846052, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0005403', 'abnormal nerve conduction', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846053, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0003889', 'enhanced sensorimotor gating', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846054, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846055, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0012006', 'abnormal hippocampus physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846056, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846057, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846058, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0003470', 'abnormal summary potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846059, 'HP:0032886', 'Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846060, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0005499', 'abnormal olfactory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846061, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0013332', 'peliosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846062, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0031310', 'abnormal cyst', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846063, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846064, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0000462', 'abnormal digestive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846065, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846066, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0002160', 'abnormal reproductive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846067, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0002108', 'abnormal muscle morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846068, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0002109', 'abnormal limb morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846069, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0002111', 'abnormal tail morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846070, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0013118', 'swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846071, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0002132', 'abnormal respiratory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846072, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846073, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0002163', 'abnormal gland morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846074, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0000685', 'abnormal immune system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846075, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0010678', 'abnormal skin adnexa morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846076, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846077, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0000003', 'abnormal adipose tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846078, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0005500', 'abnormal gustatory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846079, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0014134', 'abnormal embryo morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846080, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0020973', 'abnormal gland development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846081, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846082, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0003385', 'abnormal body wall morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846083, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0003384', 'abnormal ventral body wall morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846084, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846085, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0006281', 'abnormal tail development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846086, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0010233', 'hairless tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846087, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0003632', 'abnormal nervous system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846088, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0012382', 'abnormal blood cell physiology', 0.4166666666666667, 5.816527256141925, 1.5567764847249168, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(846089, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0020982', 'abnormal skin adnexa development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846090, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846091, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0003279', 'aneurysm', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846092, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0004134', 'abnormal chest morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846093, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.47619047619047616, 5.816527256141925, 1.6642640667505584, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(846094, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.43478260869565216, 5.816527256141925, 1.590259379464479, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(846095, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0008923', 'thoracoschisis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846096, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0000428', 'abnormal craniofacial morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846097, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0002925', 'abnormal cardiovascular development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846098, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0013113', 'greasy tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846099, 'HP:0004831', 'Recurrent thromboembolism', 'MP:0005508', 'abnormal skeleton morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(846100, 'HP:0040255', 'Aplasia/Hypoplasia of the clitoris', 'MP:0009100', 'abnormal clitoris size', 0.40425531914893614, 13.33412877350486, 2.3217218788877836, 'UPHENO:0075923', 'abnormal clitoris'),
(846101, 'HP:0007583', 'Telangiectasia macularis eruptiva perstans', 'MP:0001191', 'abnormal skin condition', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(846102, 'HP:0007583', 'Telangiectasia macularis eruptiva perstans', 'MP:0009931', 'abnormal skin appearance', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(846103, 'HP:0007583', 'Telangiectasia macularis eruptiva perstans', 'MP:0003941', 'abnormal skin development', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(846104, 'HP:0007583', 'Telangiectasia macularis eruptiva perstans', 'MP:0009563', 'dyskeratosis', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(846105, 'HP:0007583', 'Telangiectasia macularis eruptiva perstans', 'MP:0011239', 'abnormal skin coloration', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(846106, 'HP:0007583', 'Telangiectasia macularis eruptiva perstans', 'MP:0002060', 'abnormal skin morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(846107, 'HP:0012023', 'Galactosuria', 'MP:0011459', 'increased urine chloride ion level', 0.43103448275862066, 9.50911518495075, 2.0245386005797448, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(846108, 'HP:0012023', 'Galactosuria', 'MP:0030766', 'increased urine catecholamine level', 0.423728813559322, 9.50911518495075, 2.007308171486908, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(846109, 'HP:0012023', 'Galactosuria', 'MP:0011462', 'increased urine bicarbonate level', 0.4262295081967213, 9.50911518495075, 2.0132226624662093, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(846110, 'HP:0012023', 'Galactosuria', 'MP:0030778', 'increased urine citrate level', 0.4482758620689655, 9.50911518495075, 2.06463236607559, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(846111, 'HP:0012023', 'Galactosuria', 'MP:0009472', 'increased urine sulfate level', 0.423728813559322, 9.50911518495075, 2.007308171486908, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(846112, 'HP:0012023', 'Galactosuria', 'MP:0011741', 'increased urine nitrite level', 0.44642857142857145, 9.50911518495075, 2.0603739242106758, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(846113, 'HP:0012023', 'Galactosuria', 'MP:0009810', 'increased urine uric acid level', 0.45614035087719296, 9.50911518495075, 2.0826644321625793, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(846114, 'HP:0012023', 'Galactosuria', 'MP:0011735', 'increased urine ammonia level', 0.43859649122807015, 9.50911518495075, 2.0422204961274284, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(846115, 'HP:0012023', 'Galactosuria', 'MP:0011770', 'increased urine selenium level', 0.42857142857142855, 9.50911518495075, 2.01874591746079, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(846116, 'HP:0012023', 'Galactosuria', 'MP:0001758', 'abnormal urine glucose level', 0.4230769230769231, 10.668547812575419, 2.1245273314889235, 'UPHENO:0052116', 'abnormal independent continuant carbohydrate level'),
(846117, 'HP:0012023', 'Galactosuria', 'MP:0001759', 'increased urine glucose level', 0.5272727272727272, 14.87018167374507, 2.800114505900873, 'UPHENO:0080658', 'increased level of monosaccharide in urine'),
(846118, 'HP:0012023', 'Galactosuria', 'MP:0030780', 'increased urine glycerol level', 0.4426229508196721, 10.668547812575419, 2.1730494963904734, 'UPHENO:0052116', 'abnormal independent continuant carbohydrate level'),
(846119, 'HP:0012023', 'Galactosuria', 'MP:0011740', 'abnormal urine nitrite level', 0.40384615384615385, 9.150450616995217, 1.9223356334502786, 'UPHENO:0081544', 'abnormal role urine level'),
(846120, 'HP:0012023', 'Galactosuria', 'MP:0030612', 'organic aciduria', 0.4230769230769231, 9.50911518495075, 2.005763493942646, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(846121, 'HP:0012023', 'Galactosuria', 'MP:0011537', 'uraturia', 0.4262295081967213, 9.50911518495075, 2.0132226624662093, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(846122, 'HP:0012023', 'Galactosuria', 'MP:0005619', 'increased urine potassium level', 0.43103448275862066, 9.50911518495075, 2.0245386005797448, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(846123, 'HP:0012023', 'Galactosuria', 'MP:0009809', 'abnormal urine uric acid level', 0.40384615384615385, 9.150450616995217, 1.9223356334502786, 'UPHENO:0081544', 'abnormal role urine level'),
(846124, 'HP:0012023', 'Galactosuria', 'MP:0002962', 'increased urine protein level', 0.4032258064516129, 9.50911518495075, 1.9581421396550975, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(846125, 'HP:0012023', 'Galactosuria', 'MP:0011435', 'increased urine magnesium level', 0.41379310344827586, 9.50911518495075, 1.983634614395478, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(846126, 'HP:0012023', 'Galactosuria', 'MP:0011765', 'oroticaciduria', 0.41935483870967744, 9.50911518495075, 1.9969209960979344, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(846127, 'HP:0012023', 'Galactosuria', 'MP:0006316', 'increased urine sodium level', 0.43103448275862066, 9.50911518495075, 2.0245386005797448, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(846128, 'HP:0012023', 'Galactosuria', 'MP:0011470', 'increased urine creatinine level', 0.4126984126984127, 9.50911518495075, 1.9810090214321456, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(846129, 'HP:0012023', 'Galactosuria', 'MP:0030613', 'dicarboxylic aciduria', 0.4166666666666667, 9.50911518495075, 1.9905103182507777, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(846130, 'HP:0032508', 'Polyembolokoilamania', 'MP:0005403', 'abnormal nerve conduction', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846131, 'HP:0032508', 'Polyembolokoilamania', 'MP:0003470', 'abnormal summary potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846132, 'HP:0032508', 'Polyembolokoilamania', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846133, 'HP:0032508', 'Polyembolokoilamania', 'MP:0006080', 'brain ischemia', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846134, 'HP:0032508', 'Polyembolokoilamania', 'MP:0005402', 'abnormal action potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846135, 'HP:0032508', 'Polyembolokoilamania', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846136, 'HP:0032508', 'Polyembolokoilamania', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846137, 'HP:0032508', 'Polyembolokoilamania', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846138, 'HP:0032508', 'Polyembolokoilamania', 'MP:0012006', 'abnormal hippocampus physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846139, 'HP:0032508', 'Polyembolokoilamania', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846140, 'HP:0032508', 'Polyembolokoilamania', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846141, 'HP:0032508', 'Polyembolokoilamania', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846142, 'HP:0032508', 'Polyembolokoilamania', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846143, 'HP:0032508', 'Polyembolokoilamania', 'MP:0003889', 'enhanced sensorimotor gating', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846144, 'HP:0032508', 'Polyembolokoilamania', 'MP:0003880', 'abnormal central pattern generator function', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846145, 'HP:0032508', 'Polyembolokoilamania', 'MP:0002634', 'abnormal sensorimotor gating', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846146, 'HP:0032508', 'Polyembolokoilamania', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846147, 'HP:0032508', 'Polyembolokoilamania', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846148, 'HP:0032508', 'Polyembolokoilamania', 'MP:0003477', 'abnormal nerve fiber response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846149, 'HP:0032508', 'Polyembolokoilamania', 'MP:0003633', 'abnormal nervous system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846150, 'HP:0032508', 'Polyembolokoilamania', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846151, 'HP:0032508', 'Polyembolokoilamania', 'MP:0003463', 'abnormal single cell response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846152, 'HP:0032508', 'Polyembolokoilamania', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846153, 'HP:0032508', 'Polyembolokoilamania', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846154, 'HP:0032508', 'Polyembolokoilamania', 'MP:0002635', 'reduced sensorimotor gating', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846155, 'HP:0032508', 'Polyembolokoilamania', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846156, 'HP:0032508', 'Polyembolokoilamania', 'MP:0004994', 'abnormal brain wave pattern', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846157, 'HP:0032508', 'Polyembolokoilamania', 'MP:0013806', 'encephalopathy', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846158, 'HP:0032508', 'Polyembolokoilamania', 'MP:0021015', 'increased tau protein phosphorylation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846159, 'HP:0008962', 'Calf muscle hypoplasia', 'MP:0000734', 'muscle hypoplasia', 0.4791666666666667, 12.700256672302759, 2.466888658913978, 'UPHENO:0081082', 'muscle organ hypoplasia'),
(846160, 'HP:0008962', 'Calf muscle hypoplasia', 'MP:0003359', 'hypaxial muscle hypoplasia', 0.41818181818181815, 12.700256672302759, 2.304564259594281, 'UPHENO:0081082', 'muscle organ hypoplasia'),
(846161, 'HP:0003339', 'Pyrimidine-responsive megaloblastic anemia', 'MP:0013656', 'abnormal hematopoietic cell morphology', 0.41025641025641024, 7.94655706237675, 1.8055818935480081, 'UPHENO:0085118', 'abnormal hematopoietic cell morphology'),
(846162, 'HP:0003339', 'Pyrimidine-responsive megaloblastic anemia', 'MP:0002424', 'abnormal reticulocyte morphology', 0.4090909090909091, 10.15319077934013, 2.03803288641123, 'UPHENO:0088170', 'abnormal erythroid lineage cell morphology'),
(846163, 'HP:0003339', 'Pyrimidine-responsive megaloblastic anemia', 'MP:0013658', 'abnormal myeloid cell morphology', 0.425, 9.052558416233639, 1.9614630577452374, 'UPHENO:0085068', 'abnormal myeloid cell morphology'),
(846164, 'HP:0003339', 'Pyrimidine-responsive megaloblastic anemia', 'MP:0013659', 'abnormal erythroid lineage cell morphology', 0.42857142857142855, 10.15319077934013, 2.085993163186317, 'UPHENO:0088170', 'abnormal erythroid lineage cell morphology'),
(846165, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003880', 'abnormal central pattern generator function', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846166, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0011046', 'abnormal lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846167, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846168, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002634', 'abnormal sensorimotor gating', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846169, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0010822', 'pneumothorax', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846170, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0000743', 'muscle spasm', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846171, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003234', 'enhanced NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846172, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0014275', 'increased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846173, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001947', 'abnormal mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846174, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0031117', 'subdural hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846175, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0011002', 'enhanced AMPA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846176, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001846', 'increased inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846177, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003633', 'abnormal nervous system physiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846178, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0031092', 'dysgeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846179, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0011272', 'short excitatory postsynaptic current rise time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846180, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0030991', 'optic nerve inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846181, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004994', 'abnormal brain wave pattern', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846182, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846183, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0020000', 'abnormal response to antigen', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846184, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0030987', 'spinal cord inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846185, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846186, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0014255', 'increased paired-pulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846187, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0021016', 'decreased tau protein phosphorylation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846188, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846189, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846190, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0006052', 'cerebellum hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846191, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846192, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004811', 'abnormal neuron physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846193, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0008775', 'abnormal heart ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846194, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0031333', 'decreased inhibitory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846195, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846196, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0005076', 'abnormal cell differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846197, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003464', 'abnormal single cell response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846198, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0005005', 'abnormal self tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846199, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846200, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0014254', 'increased paired-pulse ratio', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846201, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0014120', 'focal seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846202, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003875', 'abnormal hair follicle regression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846203, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846204, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003674', 'oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846205, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846206, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002635', 'reduced sensorimotor gating', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846207, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0010143', 'enhanced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846208, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004558', 'delayed allantois development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846209, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846210, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0000738', 'impaired muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846211, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003990', 'decreased neurotransmitter release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846212, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003186', 'abnormal redox activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846213, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846214, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0011001', 'absence of AMPA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846215, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846216, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0005025', 'abnormal response to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846217, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0000352', 'decreased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846218, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0020096', 'high mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846219, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002064', 'seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846220, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001921', 'reduced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846221, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846222, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846223, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0009967', 'abnormal neuron proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846224, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846225, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846226, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846227, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003471', 'abnormal summary potential threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846228, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846229, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0031169', 'abnormal joint physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846230, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0011047', 'increased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846231, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003220', 'decreased spike-wave discharge type II', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846232, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0000313', 'abnormal cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846233, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846234, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001933', 'abnormal litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846235, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0012011', 'febrile seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846236, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846237, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0013136', 'genital discharge', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846238, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001666', 'abnormal intestinal absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846239, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002421', 'abnormal cell-mediated immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846240, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846241, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846242, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846243, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846244, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846245, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004143', 'muscle hypertonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846246, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0005004', 'abnormal lymphocyte anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846247, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0011270', 'decreased excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846248, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846249, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0009046', 'muscle twitch', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846250, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846251, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846252, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001475', 'reduced long-term depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846253, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0010680', 'abnormal skin adnexa physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846254, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0012111', 'failure of morula compaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846255, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001916', 'intracerebral hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846256, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002327', 'abnormal respiratory function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846257, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0031102', 'rhinorrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846258, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0012502', 'decreased hindbrain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846259, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004751', 'increased length of allograft survival', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846260, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846261, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002920', 'decreased paired-pulse facilitation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846262, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846263, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003489', 'increased channel response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846264, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001533', 'abnormal skeleton physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846265, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846266, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0012685', 'abnormal primitive streak elongation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846267, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846268, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002195', 'psychomotor seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846269, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0008271', 'abnormal bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846270, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0010559', 'heart block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846271, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0011043', 'abnormal lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846272, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846273, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846274, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002106', 'abnormal muscle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846275, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004211', 'abnormal sour taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846276, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003202', 'abnormal neuron apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846277, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846278, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846279, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846280, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002693', 'abnormal pancreas physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846281, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846282, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001790', 'abnormal immune system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846283, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002314', 'abnormal respiratory mechanics', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846284, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001499', 'abnormal kindling response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846285, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0006138', 'congestive heart failure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846286, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0011268', 'biphasic excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846287, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0010695', 'abnormal blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846288, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003866', 'abnormal defecation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846289, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001756', 'abnormal urination', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846290, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004782', 'abnormal surfactant physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846291, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0013806', 'encephalopathy', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846292, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0006082', 'CNS inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846293, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002207', 'abnormal long-term potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846294, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846295, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846296, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003635', 'abnormal synaptic transmission', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846297, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002887', 'decreased susceptibility to pharmacologically induced seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846298, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0006051', 'brainstem hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846299, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004752', 'decreased length of allograft survival', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846300, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004072', 'abnormal frontal plane axis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846301, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0014253', 'decreased paired-pulse ratio', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846302, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846303, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0006080', 'brain ischemia', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846304, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846305, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846306, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003280', 'urinary incontinence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846307, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846308, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0005403', 'abnormal nerve conduction', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846309, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846310, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004142', 'abnormal muscle tone', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846311, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001648', 'abnormal apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846312, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001496', 'audiogenic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846313, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0011274', 'short excitatory postsynaptic current decay time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846314, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846315, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0008004', 'abnormal stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846316, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001924', 'infertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846317, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846318, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0011048', 'decreased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846319, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0011994', 'increased nerve conduction velocity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846320, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001542', 'abnormal bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846321, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001984', 'abnormal olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846322, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002923', 'increased post-tetanic potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846323, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846324, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004835', 'abnormal miniature endplate potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846325, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002498', 'abnormal acute inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846326, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846327, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002133', 'abnormal respiratory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846328, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001898', 'abnormal long-term depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846329, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846330, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003475', 'increased summary potential intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846331, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003088', 'abnormal prepulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846332, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001800', 'abnormal humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846333, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0011399', 'increased endoneurial fluid pressure', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846334, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0020846', 'abnormal cell motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846335, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0012555', 'decreased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846336, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0010071', 'abnormal pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846337, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0000947', 'convulsive seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846338, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0008840', 'abnormal spike wave discharge', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846339, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846340, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0013639', 'decreased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846341, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0011432', 'decreased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846342, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003474', 'abnormal summary potential intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846343, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0021009', 'abnormal synaptic physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846344, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003216', 'absence seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846345, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003481', 'decreased nerve fiber response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846346, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0009473', 'abnormal skin exfoliation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846347, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0021082', 'abnormal cerebrospinal fluid amyloid beta 42 isoform level', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846348, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003485', 'abnormal channel response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846349, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002193', 'minimal clonic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846350, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846351, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846352, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004213', 'abnormal umami taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846353, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003483', 'decreased nerve fiber response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846354, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003217', 'increased spike-wave discharge type I', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846355, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0010653', 'abnormal Wallerian degeneration', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846356, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846357, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846358, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0008861', 'abnormal hair shedding', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846359, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0030951', 'abnormal endocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846360, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846361, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0030990', 'nerve inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846362, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846363, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0021001', 'impaired neuron physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846364, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0006001', 'abnormal intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846365, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0005671', 'abnormal response to transplant', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846366, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0012006', 'abnormal hippocampus physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846367, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004037', 'increased muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846368, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0020848', 'abnormal exocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846369, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846370, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002419', 'abnormal innate immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846371, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846372, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0031170', 'abnormal vasculature physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846373, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846374, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0014256', 'decreased paired-pulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846375, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002578', 'impaired ability to fire action potentials', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846376, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0006054', 'spinal hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846377, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846378, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846379, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0005410', 'abnormal fertilization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846380, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0020001', 'decreased response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846381, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0020002', 'increased response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846382, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001914', 'hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846383, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0009141', 'increased prepulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846384, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001912', 'increased cerebrospinal fluid production', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846385, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003927', 'increased cellular glucose import', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846386, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0013636', 'abnormal bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846387, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0008544', 'impaired olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846388, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0020412', 'abnormal amnion physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846389, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0009697', 'abnormal copulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846390, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0011271', 'prolonged excitatory postsynaptic current rise time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846391, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001500', 'decreased kindling response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846392, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0021010', 'impaired synaptic physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846393, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0006060', 'increased cerebral infarct size', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846394, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846395, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004085', 'abnormal heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846396, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0021015', 'increased tau protein phosphorylation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846397, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846398, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003091', 'abnormal cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846399, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003472', 'increased summary potential threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846400, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846401, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0011925', 'abnormal heart echocardiography feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846402, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0011267', 'abnormal excitatory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846403, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0014252', 'abnormal paired-pulse ratio', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846404, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002128', 'abnormal blood circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846405, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001761', 'abnormal urination pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846406, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846407, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0011044', 'increased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846408, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0008942', 'abnormal induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846409, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0008921', 'increased neurotransmitter release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846410, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846411, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003469', 'decreased single cell response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846412, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0031111', 'meningoencephalitis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846413, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002917', 'decreased synaptic depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846414, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0020039', 'increased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846415, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846416, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846417, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0010753', 'improved mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846418, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846419, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003470', 'abnormal summary potential', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846420, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846421, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0009142', 'decreased prepulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846422, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846423, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0010377', 'abnormal gut flora balance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846424, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0005621', 'abnormal cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846425, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846426, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846427, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0000751', 'myopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846428, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002915', 'abnormal synaptic depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846429, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003925', 'abnormal cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846430, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846431, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002885', 'abnormal AMPA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846432, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846433, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001902', 'reduced NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846434, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003476', 'decreased summary potential intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846435, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0030214', 'muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846436, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846437, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004009', 'abnormal diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846438, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0000350', 'abnormal cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846439, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001985', 'abnormal gustatory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846440, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001919', 'abnormal reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846441, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001900', 'impaired synaptic plasticity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846442, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001664', 'abnormal digestion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846443, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0010994', 'aerophagia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846444, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004768', 'abnormal axonal transport', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846445, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846446, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846447, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002888', 'abnormal NMDA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846448, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003467', 'abnormal single cell response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846449, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846450, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0030909', 'abnormal melanocyte adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846451, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004149', 'increased bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846452, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846453, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002499', 'chronic inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846454, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0011431', 'increased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846455, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002723', 'abnormal immune serum protein physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846456, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0031088', 'coughing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846457, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846458, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002164', 'abnormal gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846459, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846460, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0011082', 'abnormal gastrointestinal motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846461, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002896', 'abnormal bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846462, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001983', 'abnormal olfactory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846463, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0031402', 'decreased muscle fatigability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846464, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0030924', 'early exit from telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846465, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0008814', 'decreased nerve conduction velocity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846466, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846467, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0005645', 'abnormal hypothalamus physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846468, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0011273', 'prolonged excitatory postsynaptic current decay time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846469, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003477', 'abnormal nerve fiber response', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846470, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846471, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846472, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0031090', 'ageusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846473, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0031013', 'abnormal egg activation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846474, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0011397', 'endoneurial edema', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846475, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0000304', 'abnormal cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846476, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003480', 'increased nerve fiber response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846477, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0013559', 'abnormal exocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846478, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002916', 'increased synaptic depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846479, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004046', 'abnormal mitosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846480, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003488', 'decreased channel response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846481, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0021027', 'abnormal cerebrospinal fluid amyloid beta 40 isoform level', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846482, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003762', 'abnormal immune organ physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846483, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846484, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0010752', 'impaired mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846485, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846486, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0000316', 'cellular necrosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846487, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003482', 'increased nerve fiber response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846488, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0000920', 'abnormal myelination', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846489, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001901', 'absence of NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846490, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003490', 'decreased channel response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846491, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004495', 'decreased synaptic glutamate release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846492, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003468', 'increased single cell response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846493, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846494, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0020424', 'increased kindling response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846495, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0031098', 'abnormal sputum production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846496, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0002322', 'abnormal respiratory transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846497, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846498, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0009358', 'environmentally induced seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846499, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001943', 'abnormal respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846500, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003997', 'tonic-clonic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846501, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003566', 'abnormal cell adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846502, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0000351', 'increased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846503, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846504, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0005620', 'abnormal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846505, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0014178', 'increased brain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846506, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003008', 'enhanced long-term potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846507, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0013475', 'delayed reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846508, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0013182', 'increased spinal cord apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846509, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003218', 'decreased spike-wave discharge type I', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846510, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004512', 'anosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846511, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003466', 'decreased single cell response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846512, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003926', 'decreased cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846513, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0004513', 'avnosmia', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846514, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0012382', 'abnormal blood cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846515, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0020155', 'enhanced humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846516, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001835', 'abnormal antigen presentation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846517, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0030988', 'dysosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846518, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0001629', 'abnormal heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846519, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003077', 'abnormal cell cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(846520, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003473', 'decreased summary potential threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(846521, 'HP:0002373', 'Febrile seizure (within the age range of 3 months to 6 years)', 'MP:0003412', 'abnormal afterhyperpolarization', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
